Showing results (1901-1910 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|February 28, 2026
Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid LeukemiaJustin M Watts, Eunice S Wang, Brian A Jonas, et al.
Advances in Therapy|March 10, 2026
Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER StudyDavid Zisman, Sandeep Sahay, Debabrata Bandyopadhyay, et al.
Advances in Therapy|February 20, 2026
Hospital-Treated Severe Hypoglycemia in Type 1 Diabetes in the US: A Retrospective Claims-Based Study of Diabetes-Related Complications and Direct Medical CostsAdriana Boateng-Kuffour, Nanxin Li, Keval Chandarana, et al.
Advances in Therapy|March 17, 2026
Clinically Meaningful, Patient-Centered Endpoints for Real-World Evidence Generation in Breast Cancer: Perspectives from the Multidisciplinary TRIUMPH InitiativeSean Khozin, Nancy A Dreyer, Dominic Galante, et al.
Advances in Therapy|March 2, 2026
Impact of Home-Based Respiratory Physiotherapy in Nusinersen-Treated Patients with Spinal Muscular AtrophyMoria Be'er, Lior Shperling, Mika Rochman, et al.
Advances in Therapy|February 20, 2026
Medical Absenteeism and Premature Death in Spinal Muscular Atrophy in Sweden: A Population-Based Matched Register Study of People of Working AgeThomas Sejersen, Anne-Berit Ekström, Anna-Karin Kroksmark, et al.
Advances in Therapy|February 20, 2026
Summary of Research: Risdiplam Treatment Following Onasemnogene Abeparvovec in Individuals with Spinal Muscular Atrophy: A Multicenter Case SeriesMelissa D Svoboda, Nancy Kuntz, Carmen Leon-Astudillo, et al.
Advances in Therapy|November 22, 2007
Nutritional supplementation: is it necessary for everybody?Elmar Wienecke, Joerg Gruenwald
Advances in Therapy|December 22, 2016
Patient Satisfaction with Collection of Patient-Reported Outcome Measures in Routine CarePablo F Recinos, Cheryl J Dunphy, Nicolas Thompson, et al.
Advances in Therapy|December 22, 2016
Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in GlaucomaVanessa Andrés-Guerrero, Lucía Perucho-González, Julián García-Feijoo, et al.
Pageof 457